8 game-changing resources for infectious disease research
Explore the solutions, expert insights, and newest technologies that are driving COVID-19 and infectious disease research
23 Mar 2022
As part of our new special feature, we’ve pulled together a selection of the top resources and technologies to help you through the complexities of infectious disease research.
Read on to explore how researchers are treating sexually transmitted infections with ‘resistance-guided therapy’, and discover how to detect COVID-19 variants, while reducing both cost and time. Find solutions to the challenges of vaccine research, and discover how introducing automation to your microfluidic immunoassays could accelerate workflows and more.
Plus, register for the Infectious Disease & COVID-19 Webinar Series, and catch up on all the latest webinars in the field that can benefit your research and workflows.
VACCINATION: COVID-19 vaccine research challenges and solutions
In this application note, Sartorius explores the most common challenges associated with vaccine development and describes the solutions and technologies that are available to help you overcome them.
SEXUAL HEALTH: Combating a 'hidden pandemic' of escalating antimicrobial resistance
In this article, find out how a partnership between molecular diagnostics (MDx) innovator SpeeDx, and the Melbourne Sexual Health Centre, has led the development of a ‘resistance-guided therapy’ approach to treating and managing sexually transmitted infections (STIs).
CYTOPATHIC EFFECTS: Perform high-throughput antiviral screening
In this application note, BMG LABTECH explores how its CLARIOstar® Plus microplate reader is used in the measurement of viral cytopathic effects and in the identification of molecules with antiviral activity against viruses such as SARS-CoV-2 and respiratory syncytial virus (RSV).
SEROLOGY: COVID-19 diagnostics
In this application note from EUROIMMUN, find the full range of test systems available for PCR-based detection of SARS-CoV-2, differentiation from influenza viruses A/B, and all-round analysis of cellular and humoral immune responses.
MICROFLUIDICS: Accelerating COVID-19 R&D workflows
In this white paper, Gyros Protein Technologies illustrates the contribution of automated flow-through microfluidic immunoassays using Gyrolab® system in generating reliable data for applications in public health and the development of vaccines and antibody-based treatments.
SEQUENCING: Reducing costs and time of SARS-CoV-2 variant detection
In this application note, discover how the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit V2 from PerkinElmer, can quickly and easily detect all mutations, including those specific to the Omicron variant.
NOVEL BIOMARKERS: The role of complement C4d and calprotectin
Read this exclusive interview with Dr. Marie-Agnès Dragon-Durey, who highlights the role of complement C4d and calprotectin in viral infectious disease research and shares her work using biomarker assays produced by Svar Life Science.
Infectious Disease & COVID-19 Webinar Series
In this series of webinars, discover the latest techniques and technologies helping researchers advance their infectious disease & COVID-19 workflows.
OLIGOS: How to rapidly produce expression vectors for SARS-CoV-2 spike variants using enzymatic DNA synthesis (EDS) oligos
This webinar provides an overview of enzymatic DNA synthesis (EDS) and the core technology behind the SYNTAX System, the world’s first benchtop enzymatic DNA printer developed by DNA Script. Plus find out how one institute has leveraged EDS oligos for a variety of applications, including rRNA depletion, COVID-19 research, and mutagenesis studies.
Additional infectious disease resources:
How to develop next-generation SARS-CoV-2 immunotherapies at “pandemic pace”: Discover how a Canadian biotechnology company uses flow cytometry to facilitate the generation of high-affinity antibodies against infectious disease. Read article>>
Sample collection methods in COVID-19 testing, research, and sequencing: In this guest editorial, discover how laboratories across the world have implemented DNA/RNA Shield™ and Quick-RNA™ Viral kits in their workflows to help in the fight against COVID-19. Read article>>
Infectious disease antibodies for research and diagnostic assay development: In this application note, Merck highlights its infectious disease portfolio that features over 200 high-quality antibodies covering over 40 disease areas and backed by extensive technical expertise to support immunoassay development. Download info>>
Your recommendations:
Take a look at what other researchers all over the world are saying about the latest equipment and technologies helping scientists. Here, Alexandra Dimitropoulos, Monash University, shares her opinion on the CLARIOstar® Plus Multi-mode Microplate Reader by BMG LABTECH.
Find more news and resources in our Infectious Disease & COVID-19 Special Feature>>
